Findings

What do systematic reviews say?

1 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Improved IBDQ at week 52 · people with active UC

Vedolizumab probably leads to higher improved IBDQ at week 6 compared with placebo (moderate certainty).

2 findings from 1 review

The impact of biological interventions for ulcerative colitis on health‐related quality of life 2015 · Cochrane Headline outcomes only
RR 1.62 [1.15, 2.27]
1 study · 374 participants
Moderate
The impact of biological interventions for ulcerative colitis on health‐related quality of life 2015 · Cochrane Headline outcomes only
RR 1.67 [1.31, 2.12]
1 study · 373 participants
Moderate